Standard BioTools Inc.LABNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank93
3Y CAGR+13.3%
5Y CAGR+11.5%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+13.3%/yr
vs -3.9%/yr prior
5Y CAGR
+11.5%/yr
Consistent
Acceleration
+17.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$118.21M-29.1%
2024$166.73M+222.5%
2023$51.70M-36.4%
2022$81.31M+185.8%
2021$28.45M-58.5%
2020$68.52M+216.3%
2019$21.66M-77.3%
2018$95.40M+64.3%
2017$58.06M+65.7%
2016$35.05M-